Beam Therapeutics Inc. · NASDAQ:BEAM
Vanguard Capital Management LLC reported a 5.02% stake in Beam Therapeutics Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Capital Management LLC reported a 5.02% stake in Beam Therapeutics Inc., 5,122,475 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.02%
- Shares
- 5,122,475
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.02% | 5,122,475 |
Source
Related
- Beam Therapeutics Inc.
- Vanguard Capital Management LLC
- Beam Therapeutics Inc. shareholders
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026